Kuberaka Mariampillai

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

AI-based chest CT quantification of interstitial lung disease in idiopathic inflammatory myopathies: agreement with expert visual assessment in 107 patients.

AI-based chest CT quantification of interstitial lung disease in idiopathic inflammatory myopathies: agreement with expert visual assessment in 107 patients.

Journal: BMC pulmonary medicine

Published: November 30, 2025

The immune cell landscape analysed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren's disease.

The immune cell landscape analysed by imaging mass cytometry in the muscle of patients with inclusion body myositis associated or not with Sjögren's disease.

Journal: Rheumatology (Oxford, England)

Published: September 01, 2025

Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis.

Ultrasensitive interferons quantification reveals different cytokine profile secretion in inflammatory myopathies and can serve as biomarkers of activity in dermatomyositis.

Journal: Frontiers in immunology

Published: November 17, 2024

Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis.

Inclusion-body myositis associated with Sjögren's disease: clinical characteristics and comparison with other Sjögren-associated myositis.

Journal: Rheumatology (Oxford, England)

Published: November 10, 2023

Effect of sirolimus on muscle in inclusion body myositis observed with magnetic resonance imaging and spectroscopy.

Effect of sirolimus on muscle in inclusion body myositis observed with magnetic resonance imaging and spectroscopy.

Journal: Journal of cachexia, sarcopenia and muscle

Published: November 10, 2023

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study.

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study.

Journal: RMD open

Published: February 18, 2023

Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses.

Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses.

Journal: Rheumatology (Oxford, England)

Published: May 17, 2022

Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity.

Myostatin in idiopathic inflammatory myopathies: Serum assessment and disease activity.

Journal: Neuropathology and applied neurobiology

Published: February 07, 2022

Occurrence of focal myositis during Behçet's disease: The identification of a specific vasculitis-associated focal myopathy.

Occurrence of focal myositis during Behçet's disease: The identification of a specific vasculitis-associated focal myopathy.

Journal: Neuropathology and applied neurobiology

Published: January 01, 2022

Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.

Idiopathic inflammatory myopathies: CT characteristics of interstitial lung disease and their association(s) with myositis-specific autoantibodies.

Journal: European radiology

Published: April 21, 2021

The seasonality of Dermatomyositis associated with anti-MDA5 antibody: An argument for a respiratory viral trigger.

The seasonality of Dermatomyositis associated with anti-MDA5 antibody: An argument for a respiratory viral trigger.

Journal: Autoimmunity reviews

Published: November 14, 2020

Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial.

Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trial.

Journal: The Lancet. Rheumatology

Published: June 05, 2020

Showing 1-12 of 33

Last Updated: 09/26/2026